B. Riley Wealth Advisors Inc. Acquires New Shares in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU)

B. Riley Wealth Advisors Inc. bought a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,300 shares of the company’s stock, valued at approximately $279,000.

Other large investors have also recently made changes to their positions in the company. Thurston Springer Miller Herd & Titak Inc. bought a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the third quarter worth $43,000. Dunhill Financial LLC purchased a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares during the third quarter worth about $46,000. Headlands Technologies LLC purchased a new stake in Direxion Daily S&P Biotech Bull 3x Shares in the second quarter valued at approximately $68,000. SG Americas Securities LLC raised its stake in Direxion Daily S&P Biotech Bull 3x Shares by 82.8% in the second quarter. SG Americas Securities LLC now owns 2,142 shares of the company’s stock valued at $243,000 after purchasing an additional 970 shares in the last quarter. Finally, Foundations Investment Advisors LLC lifted its position in Direxion Daily S&P Biotech Bull 3x Shares by 25.3% during the second quarter. Foundations Investment Advisors LLC now owns 4,087 shares of the company’s stock valued at $464,000 after purchasing an additional 825 shares during the last quarter.

Direxion Daily S&P Biotech Bull 3x Shares Price Performance

Shares of NYSEARCA:LABU opened at $94.24 on Friday. The company’s fifty day moving average price is $119.87 and its 200-day moving average price is $123.87. Direxion Daily S&P Biotech Bull 3x Shares has a one year low of $80.41 and a one year high of $176.99.

About Direxion Daily S&P Biotech Bull 3x Shares

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.